The agreement combines the digital technology, implementation, and strategy solutions of ATG with the manufacturing-quality expertise of M3 BIOPHARMA.
Today we are proud to announce our internal partnership agreement with the sustainable, socially responsible life-sciences consulting firm M3 BIOPHARMA, Inc. This strategic partnership combines the leading ATG skillsets in digital technology with the Current Good Manufacturing Practices expertise of M3 BIOPHARMA, allowing both consultants to address better the myriad scientific, business, and regulatory challenges that life-sciences companies face.
As the role of technology grows within the life-sciences industry, manufacturing organizations are acknowledging the need to remain competitive through the use of efficient new digital solutions. By offering innovative technologies to the life-sciences industry, the ATG-M3 BIOPHARMA partnership combines sound business-and technology strategy, cyber-security solutions, and implementation skillsets together with leading expertise in drug manufacturing and quality operations to boost efficiencies and reduce costs for clients, especially in the areas of manufacturing, supply chain, quality systems, and regulatory compliance. M3 BIOPHARMA now is a vanguard member of the ATG Internal Partner Network, a platform of affiliated companies providing bilateral and direct access to one another’s knowledge, skillsets, and capabilities. By connecting ATG consultants with the deep life sciences expertise of M3 BIOPHARMA, the new agreement represents a big step forward in both firms’ joint capabilities to solve their clients’ most pressing challenges. Access to the network yields potential advantages in contract development, supply-chain management, technology transfer, technical writing, quality-systems risk management, regulatory compliance, secure internal-network deployment, industrial internet of things (IIoT), Industry 4.0, and quality-compliant cloud use.
‘This is an exciting new development for both our organizations,’ said Jason McKinley, ATG’s chief executive officer. ‘It presents substantial growth opportunities and allows us to help our clients tackle various scientific, business and regulatory challenges in innovative ways. The life-sciences industry is always searching for new and better ways to operate. We’re thrilled to be working with M3 BIOPHARMA to help deliver these.’
‘At M3 BIOPHARMA, we’re helping our life-sciences clients get to better business outcomes through increased operational efficiency, robust compliance, and by ensuring that manufacturing and quality operations meet required production deadlines, quality standards, and budgets,’ said Matthew Pino, M3 BIOPHARMA president. ‘Adding new digital capabilities and the IT and digital-process-consulting expertise of ATG enables us to offer life-sciences consulting services more quickly, when and where our clients need us – with surgical precision.’
About Arc Technologies Group
Arc Technologies Group is a digital technology services consultant and managed service provider. The firm advises clients ranging from startups to Fortune 500, offering digital solutions including managed services through operational-technology network implementation, cyber-security, the cloud, and digital strategy. ATG focuses on resolving process and implementation challenges, and getting things right the first time – whether it’s for a client or an internal process. At ATG, problem-solving is our passion and technology is the solution.
We focus on right the first time implementation and processes, regardless of whether they are for a client or for our own internal process.
Let us bring our passion for problem-solving to your business today!
About M3 BIOPHARMA
M3 BIOPHARMA, Inc., is a life-sciences consulting firm that provides seasoned consultants with progressive backgrounds to start-up companies and large, multinational biopharmaceutical firms. M3 BIOPHARMA oversees manufacturing and quality operations, ensuring that productions meet deadlines, quality standards, and operating budgets. The firm offers extensive experience developing and implementing manufacturing methods, quality management systems, safety protocols, and efficiency improvements for manufacturing operations so that clients comply with safety, state
and federal regulations. M3 BIOPHARMA devises strategies to improve business and operational processes and practices and translates them into plans.
Its bespoke strategies are practical and phased appropriately, certifying that personnel possess the qualifications, experience, and training necessary to support a sustainable organization.
More information is available at www.linkedin.com/in/.
Tel: +1 8774ARCTEC
Em: [email protected]